Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Incorporated scores highest on Nitro (91) and lowest on Price (31). Its PosiPenta is 59.73 out of 100, around the middle of similar companies.
On the Penta Grid this week, Ligand Pharmaceuticals Incorporated is Grid #147 of 837 in the Healthcare sector in United States, and Grid #656 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Ligand Pharmaceuticals Incorporated | 59.73 | 31 | 68 | 91 | 54 | 55 |
| Rhythm Pharmaceuticals, Inc. | 35.77 | 2 | 47 | 63 | 27 | 40 |
| Immunovant, Inc. | 45.38 | 9 | 25 | 60 | 59 | 74 |
| Doximity, Inc. | 57.09 | 27 | 77 | 47 | 81 | 53 |
| Iovance Biotherapeutics, Inc. | 53.82 | 8 | 62 | 92 | 55 | 53 |
| Teleflex Incorporated | 55.83 | 30 | 51 | 87 | 46 | 65 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | 31.14 |
| P/B ratio | 6.09 |
EEarnings
| Trailing EPS | ₹898.84 |
| Forward EPS | ₹1131.82 |
NNitro
| Price | 27992.06 |
| 52-week high | 30936.74 |
| 52-week low | 16659.41 |
| Fall from 52-week high | 9.5% |
TTorque
| Return on equity (ROE) | 21.96% |
| Debt-to-equity | 1.17 |
AAnchor
| Beta (price swings) | 1.01 |
| Market cap | ₹55,803 Cr |
| Insider holding | 2.32% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Ligand Pharmaceuticals Incorporated's PosiPenta score?
Ligand Pharmaceuticals Incorporated's PosiPenta is 59.73 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Ligand Pharmaceuticals Incorporated stand on the Penta Grid?
On the Penta Grid this week, Ligand Pharmaceuticals Incorporated is Grid #147 of 837 in the Healthcare sector in United States, and Grid #656 of 4,000 in United States.
Which PosiPenta pillar is strongest for Ligand Pharmaceuticals Incorporated?
Nitro (momentum), with a score of 91 out of 100: much better than most similar companies.
Which PosiPenta pillar is weakest for Ligand Pharmaceuticals Incorporated?
Price (valuation), with a score of 31 out of 100: weaker than most similar companies.
Has Ligand Pharmaceuticals Incorporated's PosiPenta changed since last week?
Yes, it rose 8.16 points, from 51.57 to 59.73.
PositoAI is for research and education only and is not investment advice.